Measles Outbreak in a Highly Vaccinated Population — Israel, July–August 2017

• Published in: MMWR. Morbidity and mortality weekly report Vol. 67; no. 42; pp. 1186 - 1188
• Main Authors: Avramovich, Eva, Indenbaum, Viki, Haber, Meital, Amitai, Ziva, Tsifanski, Evgeny, Farjun, Sahar, Sarig, Alona, Bracha, Adi, Castillo, Karina, Markovich, Michal Perry, Galor, Inbal
• Format: Journal Article
• Language: English
• Published: United States Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services 26-10-2018; Centers for Disease Control and Prevention
• Subjects: Adult; Disease Outbreaks; Full Report; Humans; Israel - epidemiology; Male; Measles - epidemiology; Measles - prevention & control; Measles virus - isolation & purification; Measles-Mumps-Rubella Vaccine - administration & dosage; Military Personnel - statistics & numerical data; Vaccination Coverage - statistics & numerical data; Young Adult
• ISSN: 0149-2195; 1545-861X
• DOI: 10.15585/mmwr.mm6742a4

On August 6, 2017, the Israeli Defense Force Public Heath Branch (IDFPHB) was notified of two suspected measles cases. IDFPHB conducted an epidemiologic investigation, which identified nine measles cases in a population with high measles vaccination coverage. All measles patients had signs and symptoms consistent with modified measles (i.e., less severe disease with milder rash, fever, or both, with or without other mild typical measles symptoms). A total of 1,392 contacts were identified, and 162 received postexposure prophylaxis (PEP) with measles-mumps-rubella (MMR) vaccine; the remaining contacts were followed for 21 days (one incubation period). No tertiary cases were identified.